KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Accured Expenses (2017 - 2026)

Johnson & Johnson's Change in Accured Expenses history spans 18 years, with the latest figure at -$629.0 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 90.34% to -$629.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $183.0 million, a 104.58% increase, with the full-year FY2025 number at -$5.7 billion, down 17363.64% from a year prior.
  • Change in Accured Expenses hit -$629.0 million in Q1 2026 for Johnson & Johnson, down from $499.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for JNJ hit a ceiling of $6.0 billion in Q3 2023 and a floor of -$6.5 billion in Q1 2025.
  • Historically, Change in Accured Expenses has averaged -$173.7 million across 5 years, with a median of -$629.0 million in 2026.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 263.32% in 2023 and later plummeted 585.16% in 2025.
  • Tracing JNJ's Change in Accured Expenses over 5 years: stood at -$2.8 billion in 2022, then soared by 218.14% to $3.3 billion in 2023, then crashed by 89.21% to $359.0 million in 2024, then surged by 39.0% to $499.0 million in 2025, then tumbled by 226.05% to -$629.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for JNJ at -$629.0 million in Q1 2026, $499.0 million in Q4 2025, and -$5.3 billion in Q3 2025.